Cardiovascular Events and Heart Failure in Patients With Type 2 Diabetes Treated With Dipeptidyl Peptidase-4 Inhibitors: A Meta-Analysis

Cardiovascular Events and Heart Failure in Patients With Type 2 Diabetes Treated With Dipeptidyl Peptidase-4 Inhibitors: A Meta-Analysis

Background: The global prevalence of type 2 diabetes mellitus (T2DM) continues to rise, with patients facing significantly elevated risks of cardiovascular complications, particularly heart failure (HF). Objective: This examination sought to methodically examine cardiovascular sequelae, notably hear...

Full description

Saved in:
Bibliographic Details
Main Authors: Adili Tuersun, PhD, Shufen Cui, BS, Li Han, BS, Alimu Aikebaier, BS, Yanyan Shi, BS, Gang Cheng, PhD, Lei Cheng, BS, Guo Ma, PhD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Current Therapeutic Research
Subjects:
cardiovascular death
cardiovascular outcomes
dipeptidyl peptidase 4 inhibitors
heart failure
type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X25000293
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items